Clinical Trial Update: A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer [Phase 1, Phase 2]

View source ↗

Summary

Ongoing early-phase study evaluating toripalimab with cetuximab for advanced head and neck squamous cell cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Head and Neck Squamous Cell Cancer | Phase 1, Phase 2 | Status: UNKNOWN